A detailed history of Voya Investment Management LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 108,709 shares of ALNY stock, worth $25.6 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
108,709
Previous 114,234 4.84%
Holding current value
$25.6 Million
Previous $27.8 Million 7.73%
% of portfolio
0.04%
Previous 0.03%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$233.81 - $287.01 $1.29 Million - $1.59 Million
-5,525 Reduced 4.84%
108,709 $29.9 Million
Q2 2024

Dec 03, 2024

BUY
$143.31 - $247.0 $791,787 - $1.36 Million
5,525 Added 5.08%
114,234 $27.8 Million
Q2 2024

Aug 14, 2024

BUY
$143.31 - $247.0 $6.27 Million - $10.8 Million
43,737 Added 62.04%
114,234 $27.8 Million
Q1 2024

Dec 06, 2024

SELL
$146.51 - $198.2 $5.6 Million - $7.57 Million
-38,212 Reduced 35.15%
70,497 $10.5 Million
Q1 2024

May 15, 2024

SELL
$146.51 - $198.2 $2 Million - $2.7 Million
-13,626 Reduced 16.2%
70,497 $10.5 Million
Q4 2023

Feb 14, 2024

SELL
$151.41 - $196.57 $10.6 Million - $13.8 Million
-69,981 Reduced 45.41%
84,123 $16.1 Million
Q3 2023

Nov 14, 2023

BUY
$170.77 - $211.65 $1.11 Million - $1.37 Million
6,494 Added 4.4%
154,104 $27.3 Million
Q2 2023

Aug 14, 2023

SELL
$185.01 - $212.05 $4.63 Million - $5.31 Million
-25,030 Reduced 14.5%
147,610 $28 Million
Q1 2023

May 15, 2023

SELL
$182.66 - $235.53 $2.29 Million - $2.96 Million
-12,559 Reduced 6.78%
172,640 $34.6 Million
Q4 2022

Feb 14, 2023

BUY
$185.53 - $241.31 $18.5 Million - $24 Million
99,505 Added 116.12%
185,199 $44 Million
Q3 2022

Mar 03, 2023

SELL
$138.54 - $232.0 $13.8 Million - $23.1 Million
-99,505 Reduced 53.73%
85,694 $17.2 Million
Q3 2022

Nov 14, 2022

BUY
$138.54 - $232.0 $4.78 Million - $8 Million
34,493 Added 67.37%
85,694 $17.2 Million
Q2 2022

Aug 15, 2022

SELL
$120.42 - $169.29 $852,814 - $1.2 Million
-7,082 Reduced 12.15%
51,201 $7.47 Million
Q1 2022

May 16, 2022

SELL
$127.18 - $173.91 $56,467 - $77,216
-444 Reduced 0.76%
58,283 $9.52 Million
Q4 2021

Feb 14, 2022

BUY
$159.56 - $209.29 $3.39 Million - $4.45 Million
21,248 Added 56.69%
58,727 $9.96 Million
Q3 2021

Nov 15, 2021

SELL
$169.75 - $207.73 $59,412 - $72,705
-350 Reduced 0.93%
37,479 $7.08 Million
Q2 2021

Aug 16, 2021

SELL
$128.63 - $176.89 $51,837 - $71,286
-403 Reduced 1.05%
37,829 $6.41 Million
Q1 2021

May 17, 2021

SELL
$126.83 - $175.69 $316,187 - $437,995
-2,493 Reduced 6.12%
38,232 $5.4 Million
Q4 2020

Feb 16, 2021

SELL
$122.97 - $147.0 $257,622 - $307,965
-2,095 Reduced 4.89%
40,725 $5.29 Million
Q3 2020

Nov 16, 2020

SELL
$121.19 - $165.49 $155,365 - $212,158
-1,282 Reduced 2.91%
42,820 $6.24 Million
Q2 2020

Aug 14, 2020

BUY
$104.21 - $156.44 $917,777 - $1.38 Million
8,807 Added 24.95%
44,102 $6.53 Million
Q1 2020

May 15, 2020

SELL
$93.12 - $133.99 $63,507 - $91,381
-682 Reduced 1.9%
35,295 $3.84 Million
Q4 2019

Feb 14, 2020

SELL
$74.51 - $124.23 $1.14 Million - $1.9 Million
-15,278 Reduced 29.81%
35,977 $4.14 Million
Q3 2019

Nov 14, 2019

SELL
$70.9 - $87.82 $73,452 - $90,981
-1,036 Reduced 1.98%
51,255 $4.12 Million
Q2 2019

Aug 14, 2019

BUY
$65.86 - $92.79 $377,641 - $532,057
5,734 Added 12.32%
52,291 $3.79 Million
Q1 2019

May 15, 2019

SELL
$72.76 - $93.45 $703,225 - $903,194
-9,665 Reduced 17.19%
46,557 $4.35 Million
Q4 2018

Feb 14, 2019

BUY
$62.67 - $88.33 $409,360 - $576,971
6,532 Added 13.15%
56,222 $4.1 Million
Q3 2018

Nov 14, 2018

SELL
$87.52 - $122.67 $275,775 - $386,533
-3,151 Reduced 5.96%
49,690 $4.35 Million
Q2 2018

Aug 14, 2018

BUY
$88.31 - $107.8 $751,783 - $917,701
8,513 Added 19.2%
52,841 $5.2 Million
Q1 2018

May 15, 2018

BUY
$115.92 - $148.54 $1.62 Million - $2.07 Million
13,940 Added 45.87%
44,328 $5.28 Million
Q4 2017

Feb 14, 2018

BUY
$114.49 - $139.98 $115,749 - $141,519
1,011 Added 3.44%
30,388 $3.86 Million
Q3 2017

Nov 14, 2017

BUY
$72.53 - $118.27 $2.13 Million - $3.47 Million
29,377
29,377 $3.45 Million

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $29B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.